CHUV
Les activités du CHUV
MENU
Service
des maladies infectieuses
Accueil > Recherche > Publications > 2014
Dec 2014

Kritikos A et al,   Identification of Propionibacterium avidum from a breast abscess: an overlooked etiology of clinically significant infections

New Microbes New Infect. 2014
Dec 19;4:9-10

Dec 2014

Gayet-Ageron A et al,  Performance of the 47kDa protein membrane versus DNA polymerase I genes for detection of Treponema pallidum by polymerase chain reaction in ulcers.

J Clin Microbiol. 2014
Dec 17. pii: JCM.03444-14

Dec 2014

Asner S et al. Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms.

Clin Microbiol Infect. 2014
Dec;20(12):1246-53

Dec 2014

Textoris J et al,   A revival for immunoglobulin therapy in septic shock?.

Intensive Care Med. 2014
Dec;40(12):1957-9

Dec 2014

Rio-Marques L et al,   The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus

Microb Drug Resist. 2014
Dec;20(6):539-43

Dec 2014

Terczyńska-Dyla E et al,   Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Nat Commun. 2014
Dec 23;5:5699

Nov 2014

Wójtowicz A et al,   IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation

J Infect Dis. 2014
Nov 14. pii: jiu636. [Epub ahead of print]

Nov 2014

Molina JM et al,   Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

J Int AIDS Soc. 2014
Nov 2;17(4 Suppl 3):19490

Nov 2014

Aebi-Popp K et al,   Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study

J Int AIDS Soc. 2014
Nov 2;17(4 Suppl 3):19535

Nov 2014

Savva A & Roger T,   Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases

Front Immunol. 2013
Nov 18;4:387

Nov 2014

Merz L et al,   Investigating barriers in HIV-testing oncology patients. The IBITOP study: phase I.

J Int AIDS Soc. 2014
Nov 2;17(4 Suppl 3):19622

Nov 2014

Mercier T et al,   High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate

J Chromatogr A. 2014
Nov 21;1369:52-63

Nov 2014

Kouyos RD et al,   Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide

J Infect Dis. 2014
Nov 15;210(10):1555-61

Nov 2014

Gisler V et al,   AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be

J Int AIDS Soc. 2014
Nov 2;17(4 Suppl 3):19621

Nov 2014

Stern M et al,   Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment

Transplantation. 2014
Nov 15;98(9):1013-8

Oct 2014

Rosin C et al,   Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study

HIV Med. 2014
Oct 20

Oct 2014

Mosimann V et al,   Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital

HIV Med. 2014
Nov;15(10):631-4

Oct 2014

Glass T & Cavassini M,   Asking about adherence - from flipping the coin to strong evidence

Swiss Med Wkly. 2014
Oct 2;144:w14016

Oct 2014

Manuel O et al,   Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.

J Infect Dis. 2014
Oct 9. pii: jiu557

Oct 2014

Gonzales A et al,   KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients

Genes Immun. 2014
Oct;15(7):495-9

Sept 2014

Young J et al,   The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir

HIV Med. 2014
Sep;15(8):505-10

Sept 2014

Maubon D et al,   Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?.

Intensive Care Med. 2014
Sep;40(9):1241-55

Sept 2014

Perreau M et al,   Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders

J Exp Med. 2014
Sep 22;211(10):2033-45

Sept 2014

Arab-Alameddine A et al,   Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

J Antimicrob Chemother. 2014
Sep;69(9):2489-98

Sept 2014

Metzner KJ et al,   Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients

AIDS. 2014
Sep 24;28(15):2231-9

Sept 2014

Morard D et al,   Clinical significance of the CCR5delta32 allele in hepatitis C

PLoS One. 2014
Sep 5;9(9):e106424

Sept 2014

Kumar V et al,   Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.

Nat Commun. 2014
Sep 8;5:4675

Sept 2014

Tissot F et al,   Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality.

J Infect. 2014
Sep;69(3):226-34

Sept 2014

Vermeiren P et al,   Influenza vaccination and humoral alloimmunity in solid organ transplant recipients

Transpl Int. 2014
Sep;27(9):903-8

Sept 2014

Gavaldà J et al,   A special issue on infections in solid organ transplant recipients

Clin Microbiol Infect. 2014
Sep;20 Suppl 7:1-3

Sept 2014

Yusuf E et al,   The potential use of microcalorimetry in rapid differentiation between septic arthritis and other causes of arthritis

Eur J Clin Microbiol Infect Dis. 2014
Sep 25. [Epub ahead of print]

Sept 2014

Rüeger S et al,   Impact of common risk factors of fibrosis progression in chronic hepatitis C

Gut. 2014
Sep 11. pii: gutjnl-2014-306997. doi: 10.1136/gutjnl-2014-306997

Aug 2014

von Braun A et al,   Antiretroviral therapy

Ther Umsch. 2014
Aug;71(8):461-8

Aug 2014

Krummenacher I et al,   Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme

Int J Clin Pharm. 2014
Aug;36(4):716-24

Aug 2014

Bibert S et al,   The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients

AIDS. 2014
Aug 24;28(13):1885-9

July 2014

Guidi M et al,   Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry

Antivir Ther. 2014
Jul 17

July 2014

Hoggart CJ et al,   Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index

PLoS Genet. 2014
Jul 31;10(7):e1004508

July 2014

Castro E et al,   HIV-1 superinfection with a triple-class drug-resistant strain in a patient successfully controlled with antiretroviral treatment

AIDS. 2014
Jul 31;28(12):1840-4

July 2014

Thacher EG et al,   Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial

AIDS. 2014
Jul 31;28(12):1769-81

July 2014

Ingle SM et al,   Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients

Clin Infect Dis. 2014
Jul 15;59(2):287-97

July 2014

Orasch C et al,   Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.

Clin Microbiol Infect. 2014
Jul;20(7):698-705

June 2014

Doco-Lecompte T et al,   A-24: Modification de la thérapie antirétrovirale en alternative au traitement par statines pour les patients séropositifs pour le VIH présentant un risque cardiovasculaire bas ou intermédiaire : l'essai prospectif ETRALL

Med Mal Infect. 2014
Jun;44(6 Suppl):25

June 2014

Gié O et al,   Clostridial colitis: diagnosis and strategies for management

Rev Med Suisse. 2014
Jun 11;10(434):1309-13

June 2014

Tissot F et al,   Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection

Transplantation. 2014
Jun 15;97(11):1192-7

May 2014

Mohammadi P et al,   Dynamics of HIV latency and reactivation in a primary CD4+ T cell model

PLoS Pathog. 2014
May 29;10(5):e1004156

May 2014

Wang Q et al,   Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone

HIV Clin Trials. 2014
May-Jun;15(3):92-103

April 2014

Boillat-Blanco N et al,   Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study

Antivir Ther. 2014
Jun 25

April 2014

Calandra T,   Infectious disease in Switzerland: we want to continue to play in the League of Champions!

Rev Med Suisse. 2014
Apr 23;10(427):899-900.

April 2014

Merz L et al,   Breast infections

Rev Med Suisse. 2014
Apr 23;10(427):925-6, 928-30

April 2014

Tissot F & Maillard MH,   Clostridium difficile infections: update on new European recommendations

Rev Med Suisse. 2014
Apr 23;10(427):913-6, 918-9

April 2014

Gervais P et al,   Skin infections due to rapid-growing mycobacteria

Rev Med Suisse. 2014
Apr 23;10(427):931-4

April 2014

Schibler M et al,   Intracerebral HIV replication despite an efficient antiretroviral treatment: clinical impact and management.

Rev Med Suisse. 2014
Apr 23;10(427):908, 910-2

April 2014

Wójtowicz A et al,   Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients.

Crit Care Med. 2014
Apr;42(4):e304-8

March 2014

Voide C et al,   Cerebral nocardiosis mimicking multiple brain metastases in a patient with locally advanced non-small-cell lung cancer

J Thorac Oncol. 2014
Mar;9(3):e24-6

March 2014

Bassetti M et al,   What's new in antimicrobial use and resistance in critically ill patients?

Intensive Care Med. 2014
Mar;40(3):422-6

Feb 2014

Bucheli E et al,   Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study

Transpl Infect Dis. 2014
Feb;16(1):26-36

Feb 2014

Zbinden D & Manuel O,   Influenza vaccination in immunocompromised patients: efficacy and safety

Immunotherapy. 2014
6(2):131-9

Feb 2014

Covolo L et al,   The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection

Aliment Pharmacol Ther. 2014
Feb;39(3):322-30

Jan 2014

Delaloye J & Calandra T,   Invasive candidiasis as a cause of sepsis in the critically ill patient

Virulence. 2014
Jan 1;5(1):161-9

Jan 2014

Entenza JM et al,   Rapid detection of Staphylococcus aureus strains with reduced susceptibility to vancomycin by isothermal microcalorimetry

J Clin Microbiol. 2014
Jan;52(1):180-6

Jan 2014

Voide C et al, Infectious diseases

Rev Med Suisse. 2014
Jan 15;10(412-413):61-5